Skip to main content

NICE Ltd. (NICE) Stock Forecast

Data as of Aug 3, 2026

Technology · Current price $99.21 (+0.31%)

Consensus Target
$118.80
Upside
+15.9%
Analysts
15
Rating
Buy(2.47)

Price Target Range

Low $100.00Consensus $118.80High $130.00
▲ Current $99.21

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy6
Hold4
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

NICE vs Sector & Market

MetricNICETechnology AvgLarge Cap Avg
Analyst Rating2.472.362.42
Analyst Count151419
Target Upside+15.9%+1911.9%+17.1%
P/E Ratio10.2737.6743.33

Revenue Estimates

PeriodLowAvgHigh#
2027-03-31$826M$832M$839M5
2027-06-30$844M$851M$858M5
2027-09-30$866M$873M$880M5
2027-12-31$924M$932M$939M5
2028-03-31$919M$926M$933M4
2028-06-30$943M$950M$958M4
2028-09-30$976M$984M$992M4
2028-12-31$1.04B$1.05B$1.06B4

EPS Estimates

PeriodLowAvgHigh#
2027-03-31$2.84$2.87$2.894
2027-06-30$2.94$2.97$3.004
2027-09-30$3.12$3.15$3.184
2027-12-31$3.39$3.43$3.464
2028-03-31$3.36$3.40$3.435
2028-06-30$3.53$3.57$3.615
2028-09-30$3.80$3.84$3.875
2028-12-31$4.16$4.21$4.255

Frequently Asked Questions

What is the analyst consensus for NICE?

The consensus among 15 analysts covering NICE Ltd. (NICE) is Buy with an average price target of $118.80.

What is the highest price target for NICE?

The highest analyst price target for NICE is $130.00.

What is the lowest price target for NICE?

The lowest analyst price target for NICE is $100.00.

How many analysts cover NICE?

15 analysts have issued ratings for NICE Ltd. in the past 12 months.

Is NICE a buy or sell right now?

Based on 15 analyst ratings, NICE has a consensus rating of Buy (2.47/5) with a +15.9% upside to the consensus target of $118.80.

What are the earnings estimates for NICE?

Analysts estimate NICE will report EPS of $2.87 for the period ending 2027-03-31, with revenue estimated at $832M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.